MX2012004118A - Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales. - Google Patents

Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales.

Info

Publication number
MX2012004118A
MX2012004118A MX2012004118A MX2012004118A MX2012004118A MX 2012004118 A MX2012004118 A MX 2012004118A MX 2012004118 A MX2012004118 A MX 2012004118A MX 2012004118 A MX2012004118 A MX 2012004118A MX 2012004118 A MX2012004118 A MX 2012004118A
Authority
MX
Mexico
Prior art keywords
animals
preventing
methods
muscle atrophy
treating sarcopenia
Prior art date
Application number
MX2012004118A
Other languages
English (en)
Inventor
Sunil Kochhar
Yuanlong Pan
Serge Andre Dominique Rezzi
Francoise-Pierre Martin
Emma Peretrepat
Sebastiano Collino
Francia Arce Vera
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2012004118A publication Critical patent/MX2012004118A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Abstract

La invención proporciona métodos para uno o más de prevenir o tratar sarcopenia y atrofia muscular en animales. Los métodos comprenden administrar isoflavonas a los animales, de preferencia en cantidades de aproximadamente 0.001 a alrededor de 10 g/kg/día.
MX2012004118A 2009-10-09 2010-10-08 Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales. MX2012004118A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27863309P 2009-10-09 2009-10-09
PCT/US2010/002722 WO2011043827A1 (en) 2009-10-09 2010-10-08 Methods for preventing or treating sarcopenia and muscle atrophy in animals

Publications (1)

Publication Number Publication Date
MX2012004118A true MX2012004118A (es) 2012-05-08

Family

ID=43857050

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012004118A MX2012004118A (es) 2009-10-09 2010-10-08 Metodos para prevenir o tratar sarcopenia y atrofia muscular en animales.

Country Status (12)

Country Link
US (1) US9301941B2 (es)
EP (1) EP2485740B1 (es)
JP (1) JP6122638B2 (es)
CN (1) CN102573857A (es)
AU (1) AU2010303872B2 (es)
BR (1) BR112012008238A2 (es)
CA (1) CA2776950C (es)
ES (1) ES2688447T3 (es)
IN (1) IN2012DN02624A (es)
MX (1) MX2012004118A (es)
RU (1) RU2558534C2 (es)
WO (1) WO2011043827A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11090313B2 (en) 2010-05-20 2021-08-17 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
CA2838275C (en) * 2011-06-06 2021-08-10 University Of Iowa Research Foundation Methods for inhibiting muscle atrophy
US9913823B2 (en) * 2011-10-18 2018-03-13 Amorepacific Corporation SIRT 1 activator including syringaresinol
KR102459500B1 (ko) * 2014-04-28 2022-10-26 산토리 홀딩스 가부시키가이샤 퀘르세틴 배당체를 함유하는 근위축 억제제
EP3256004A1 (en) 2015-02-13 2017-12-20 Mars, Incorporated Pet food feeding system
KR20170002846A (ko) 2015-06-30 2017-01-09 (주)아모레퍼시픽 콩잎 추출물을 유효성분으로 함유하는 근질환 억제 및 예방용 조성물
GB201522304D0 (en) * 2015-12-17 2016-02-03 Mars Inc Food product for reducing muscle breakdown
CN108635571B (zh) * 2018-07-19 2021-10-22 西安交通大学医学院第一附属医院 鸢尾素(irisin)在制备预防及治疗重症急性胰腺炎药物中的应用
AU2020356989A1 (en) * 2019-10-04 2022-05-26 Suntory Holdings Limited Composition for suppression of decrease in muscle mass, prevention of decrease therein, maintenance thereof, recovery thereof or increase therein
KR102623198B1 (ko) * 2020-02-26 2024-01-10 한국 한의학 연구원 돌콩 추출물을 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소의 예방, 개선 또는 치료용 조성물
RU2756154C1 (ru) * 2020-11-13 2021-09-28 Митхат Зульфугар-Оглы Гасанов Способ диагностики саркопении у пациентов с хронической болезнью почек 5д стадии, получающих лечение программным гемодиализом
WO2023140407A1 (ko) * 2022-01-21 2023-07-27 경상국립대학교병원 쿠메스트롤을 포함하는 근감소증 예방 또는 치료용 약학 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU166380B (es) 1973-07-09 1975-03-28
US6887499B2 (en) 2000-05-22 2005-05-03 Enitan A. Bababunmi Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease
EP1192943A3 (en) * 2000-09-28 2002-11-27 Pfizer Products Inc. Use of growth hormone secretagogues in conjunction with physical exercise
AUPR846401A0 (en) * 2001-10-25 2001-11-15 Novogen Research Pty Ltd 6-Hydroxy isoflavones, derivatives and medicaments involving same
JP5384777B2 (ja) * 2001-12-18 2014-01-08 有限会社大長企画 強筋肉剤、抗炎症剤
US20070185012A1 (en) * 2003-07-10 2007-08-09 Rajadhyaksha V J Glycopeptides for the treatment of als and other metabolic and autoimmune disorders
JP2007519743A (ja) * 2004-01-29 2007-07-19 エリクシアー ファーマシューティカルズ， インコーポレイテッド ウイルス障害の処置
CA2559974C (en) * 2004-03-17 2012-08-14 Nestec S.A. Compositions and methods for reducing or preventing obesity
WO2007134867A2 (en) * 2006-05-24 2007-11-29 Dsm Ip Assets B.V. Treating muscular disorders and improving muscular function
MX2009001962A (es) * 2006-08-24 2009-04-30 Univ Tennessee Res Foundation Acilanilidas substituidas y metodos de uso de las mismas.

Also Published As

Publication number Publication date
US20120238515A1 (en) 2012-09-20
EP2485740A4 (en) 2013-04-03
RU2012118686A (ru) 2013-11-20
JP2013507361A (ja) 2013-03-04
CA2776950A1 (en) 2011-04-14
AU2010303872A1 (en) 2012-04-19
EP2485740A1 (en) 2012-08-15
CA2776950C (en) 2023-11-21
BR112012008238A2 (pt) 2017-06-06
RU2558534C2 (ru) 2015-08-10
IN2012DN02624A (es) 2015-05-22
JP6122638B2 (ja) 2017-04-26
AU2010303872B2 (en) 2016-06-23
WO2011043827A1 (en) 2011-04-14
CN102573857A (zh) 2012-07-11
US9301941B2 (en) 2016-04-05
ES2688447T3 (es) 2018-11-02
EP2485740B1 (en) 2018-08-29

Similar Documents

Publication Publication Date Title
IN2012DN02624A (es)
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
IN2012DN00624A (es)
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
MY161495A (en) Virus like particle compositions and methods of use
IN2012DN00572A (es)
MX343135B (es) Compuestos de tipo fumagilol y métodos de realización y uso de los mismos.
WO2009129246A3 (en) Compositions and methods for preparing and using same
MX2009009761A (es) Composiciones y estuches para tratamiento de la influenza.
IN2012DN02177A (es)
IN2012DN02730A (es)
IN2012DN00754A (es)
MX2010003013A (es) Inhibicion de angiogenesis.
MX2009010960A (es) Compuestos heterociclicos y sus metodos de uso.
TN2011000482A1 (en) Organic compounds and their uses
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
TNSN08400A1 (en) Organic compounds and their uses
MX2011014019A (es) Derivados de diazahomoadamantano y sus metodos de uso.
IN2012DN02471A (es)
MX2009005725A (es) Metodos y composiciones para tratamiento y monitoreo de tratamiento de trastornos asociados con il-13.
MX368459B (es) Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central.
MX2013011996A (es) Metodos para regular la expresion de genes de sirtuina.
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
EA201200428A1 (ru) Композиция и способ для лечения ожирения
IN2012DN03187A (es)

Legal Events

Date Code Title Description
FG Grant or registration